Gillis S
J Clin Immunol. 1983 Jan;3(1):1-13. doi: 10.1007/BF00919133.
Since its discovery as a T-cell growth factor, interleukin 2 (IL-2) has attracted considerable scientific attention, not only as a useful reagent for the maintenance of large numbers of effector T lymphocytes but as a potentially potent immunoregulatory molecule, which could be of therapeutic usefulness in a number of clinical conditions. Outlined in this communication is a summary of the more salient biochemical features of murine and human IL-2, as well as the results of initial molecular biology experimentation aimed at the eventual production of IL-2 by recombinant DNA methodologies. These studies, together with those detailing the in vivo effectiveness of IL-2 therapy in a number of murine model situations, provide a current glimpse of future IL-2 aims and directions.
自白细胞介素2(IL-2)作为一种T细胞生长因子被发现以来,它不仅作为维持大量效应T淋巴细胞的有用试剂,而且作为一种潜在的强效免疫调节分子,在许多临床病症中可能具有治疗作用,从而吸引了相当多的科学关注。本通讯概述了小鼠和人IL-2更显著的生化特性,以及旨在最终通过重组DNA方法生产IL-2的初步分子生物学实验结果。这些研究,连同那些详细描述IL-2疗法在多种小鼠模型情况下体内有效性的研究,提供了对未来IL-2目标和方向的当前一瞥。